Nan Fung Group Holdings’s Rhythm Pharmaceuticals RYTM Stock Holding History

Nan Fung Group Holdings’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.45M	Hold	49,120	–	–	4.15%	6
2026 Q1	$4.27M	Hold	49,120	–	–	3.52%	7
2025 Q4	$5.26M	Hold	49,120	–	–	4.71%	7
2025 Q3	$4.96M	Hold	49,120	–	–	8.32%	5
2025 Q2	$3.1M	Hold	49,120	–	–	4.89%	8
2025 Q1	$2.6M	Hold	49,120	–	–	2.12%	17
2024 Q4	$2.75M	Hold	49,120	–	–	2.35%	18
2024 Q3	$2.57M	Hold	49,120	–	–	2.22%	17
2024 Q2	$2.02M	Hold	49,120	–	–	2.15%	14
2024 Q1	$2.13M	Buy	49,120 +9,050	+23%	+$396K	1.97%	15
2023 Q4	$1.84M	Hold	40,070	–	–	1.15%	16
2023 Q3	$919K	Hold	40,070	–	–	0.74%	20
2023 Q2	$661K	Buy	40,070 +7,550	+23%	+$136K	0.42%	28
2023 Q1	$580K	Hold	32,520	–	–	0.39%	30
2022 Q4	$947K	Buy	+32,520	New	+$836K	0.65%	21

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nan Fung Group Holdings's RYTM Position: Q2 2026 in Review

Nan Fung Group Holdings held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 49,120 shares worth $5.45M. The position accounts for 4.15% of the portfolio, ranked #6.

Nan Fung Group Holdings first reported a position in RYTM in Q4 2022 and has held it in 15 quarters since. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Nan Fung Group Holdings held 49,120 shares of Rhythm Pharmaceuticals worth $5.45M as of Q2 2026.
Nan Fung Group Holdings left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
Rhythm Pharmaceuticals made up 4.15% of Nan Fung Group Holdings's portfolio in Q2 2026, its #6 holding.
Nan Fung Group Holdings first reported a position in Rhythm Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.